medtech tony and chris

Leading injection moulder, Boddingtons, enjoyed a succession of quality enquiries over the two days of last week’s UK’s Med-Tech exhibition, NEC Birmingham.

Boddingtons CEO Andy Tibbs also presented the company’s features at the shows Introducing Stage on the afternoon of the first day. ‘We had a very fruitful time last week in Birmingham,’ said Tibbs. ‘We are now very busy this coming month with the most pressing customer needs arising. We have also already reconfirmed the Boddingtons presence at MTI EXPO 2020, April 1-2, 2020.

 

andy -Medtech

CEO Andy Tibbs at the shows Introducing Stage

The Boddingtons stand – the biggest ever – took pride of place at the front of the Med-Tech exhibition and the company’s sponsorship of all the lanyard tags at the show ensured that the Boddingtons name and presence was always to the fore.

The relocation of MTI EXPO from Coventry’s Ricoh Arena to Birmingham’s NEC was generally considered to have boosted the appeal and the visitor footfall of the annual event. The conference and seminar programmes were also very well attended.

Duncan Wood, CEO of show organisers, Rapid News Group, said that ‘we are delighted with another significant step forward for the event as we work to creating a defining event experience for the UK med-tech sector.’

Prestige Boddingtons customer Cytosystems took a share in the limelight – showcasing its life-saving medical device – Bladder Light – on the Boddingtons stand. This innovation is currently being trialled through the UK’s NHS and is set to be deployed in the early detection of Bladder Cancer.

Boddingtons has been involved in the design and development of this product innovation from the outset and will enter its work for this years Plastics Industry Awards.

Since the launch of its £4.6m manufacturing facility in early 2017, Boddingtons has steadily expanded the scope and volume of its med-tech manufacturing services. The company is certified to ISO13485 and ISO9001 Quality Management Systems Requirements and is also compliant with FDA 21 CFR Part 820.

Boddingtons is currently working towards the international MDSAP qualification for the medical industry– a commitment involving some £80,000 over the next three years resulting in a medical product standard that has no frontiers and is completely universal.

Leave a Reply

Your email address will not be published. Required fields are marked *